Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Frontiers in Medicine|April 8, 2022
Changes in Influenza Activity and Circulating Subtypes During the COVID-19 Outbreak in ChinaLuyan Zheng, Jinjin Qi, Jie Wu, et al.
Cell Communication and Signaling : CCS|August 18, 2023
A new perspective on mesenchymal stem cell-based therapy for liver diseases: restoring mitochondrial functionYelei Cen, Guohua Lou, Jinjin Qi, et al.
Antioxidants (Basel, Switzerland)|January 21, 2023
Adipose-Derived Mesenchymal Stem Cells Inhibit JNK-Mediated Mitochondrial Retrograde Pathway to Alleviate Acetaminophen-Induced Liver InjuryYelei Cen, Guohua Lou, Jinjin Qi, et al.
Journal of Translational Medicine|March 21, 2019
Altered PGE2-EP2 is associated with an excessive immune response in HBV-related acute-on-chronic liver failureYunyun Wang, Chao Chen, Jinjin Qi, et al.
American Journal of Physiology. Cell Physiology|June 27, 2023
Decreased miR-17-92 cluster correlates with senescence features, disrupted oxidative homeostasis, and impaired therapeutic efficacy of mesenchymal stem cellsYelei Cen, Jinjin Qi, Liang Chen, et al.
Cell & Bioscience|January 8, 2021
Selonsertib, a potential drug for liver failure therapy by rescuing the mitochondrial dysfunction of macrophage via ASK1-JNK-DRP1 pathwayGuohua Lou, Aichun Li, Yelei Cen, et al.
Stem Cell Research & Therapy|November 23, 2025
Adipose-derived mesenchymal stem cell therapy modulates mitochondrial function to attenuate acetaminophen-induced liver injury by DDIT4/PGC-1α axisYelei Cen, Caixia Xia, Shouhan Yao, et al.
Ebiomedicine|September 11, 2018
AMSC-derived exosomes alleviate lipopolysaccharide/d-galactosamine-induced acute liver failure by miR-17-mediated reduction of TXNIP/NLRP3 inflammasome activation in macrophagesYanning Liu, Guohua Lou, Aichun Li, et al.
BMC Infectious Diseases|November 11, 2022
Expression changes of Tim-3 as one of supplementary indicators for monitoring prognosis of liver pathological changes in chronic HBV infectionShanshan Wu, Xinfang Du, Guohua Lou, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 4, 2020
MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathwayGuohua Lou, Liang Chen, Caixia Xia, et al.
Pageof 2